Cargando…

P04-30. Sorting of infectious and non-infectious viral particles by Env-specific mAb

Detalles Bibliográficos
Autores principales:	Stieh, DJ, Fischetti, L, Buff, V, Armanasco, N, Shattock, R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767960/ http://dx.doi.org/10.1186/1742-4690-6-S3-P58

Ejemplares similares

P04-33. Mechanisms of HIV-1 antibody mediated inhibition in Monomac-1 and MDM
por: Fischetti, L, et al.
Publicado: (2009)

Discrete partitioning of HIV-1 Env forms revealed by viral capture
por: Stieh, Daniel J., et al.
Publicado: (2015)

Cellular tools for biosimilar mAb analysis
por: Lindemann, Carsten, et al.
Publicado: (2013)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
por: Nabi, G, et al.
Publicado: (2009)

Novel strategy for a high-yielding mAb-producing CHO strain (overexpression of non-coding RNA enhanced proliferation and improved mAb yield)
por: Tabuchi, Hisahiro
Publicado: (2013)

P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones
por: Siddiqui, AA, et al.
Publicado: (2009)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

Viral vector delivery of Env trimer immunogens
por: Parks, CL, et al.
Publicado: (2012)

P04-24. Frequencies of HIV Env-specific B cells and neutralizing antibodies during DNA-prime/protein-boost immunization with three different Env immunogens*
por: Tawde, P, et al.
Publicado: (2009)

Characterization of mAb aggregates in a mammalian cell culture production process
por: Paul, Albert, et al.
Publicado: (2013)

Deamidated gluten: specific detection and characterisation with INRA-DG1 mAb
por: Tranquet, Olivier, et al.
Publicado: (2015)

Influence of hormones and HIV infection on viral transport
por: Stieh, DJ, et al.
Publicado: (2012)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

P04.21. What infectious disease (ID) physicians believe about integrative medicine (IM) modalities
por: Shere-Wolfe, K, et al.
Publicado: (2012)

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12
por: Tumba, NL, et al.
Publicado: (2012)

The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Env diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine
por: Lin, Yuezhi, et al.
Publicado: (2020)

Sorting of small infectious virus particles by flow virometry reveals distinct infectivity profiles
por: Gaudin, Raphaël, et al.
Publicado: (2015)

P04.61. Do infectious disease (ID) physicians use cranberry for prevention of urinary tract infections (UTI)?
por: Shere-Wolfe, K, et al.
Publicado: (2012)

P04.83. What factors influence the use of integrative medicine (IM) modalities by infectious disease (ID) physicians?
por: Shere-Wolfe, K, et al.
Publicado: (2012)

Host cell protein platform assay development for therapeutic mAb bioprocessing using mammalian cells
por: Kochanowski, Nadine, et al.
Publicado: (2015)

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014)

P04.02. How familiar are infectious disease (ID) physicians with integrative medicine (IM) modalities and are they willing to recommend them?
por: Shere-Wolfe, K, et al.
Publicado: (2012)

Evolving trends in mAb production processes
por: Shukla, Abhinav A., et al.
Publicado: (2017)

State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017)

How to assess chemically defined media and feeds from 9 suppliers on CHO cells producing mAb
por: Polès-Lahille, Aurore, et al.
Publicado: (2013)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes
por: Guiducci, Serena, et al.
Publicado: (2012)

Stability enhancement in a mAb and Fab coformulation
por: Zhang, Hongyu, et al.
Publicado: (2020)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

A mAb for the detection of the antiretroviral drug emtricitabine
por: Youngpairoj, Ae S., et al.
Publicado: (2022)

Structural analyses of antigen binding similarities and differences between rabbit and human anti-gp120 V3 mAbs
por: Pan, R, et al.
Publicado: (2012)

Short constrained peptides derived from phage display libraries as epitope models: the case of mAb 2F5
por: Palacios-Rodriguez, Y, et al.
Publicado: (2012)

Biophysical dissection of the antigen-antibody interaction of the broadly reactive anti-V3 human mAb 447-52D
por: Killikelly, A, et al.
Publicado: (2012)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology
por: Lin, WeiYu, et al.
Publicado: (2020)

Generation, characterization and therapeutic potential of anti-feline TNF-alpha MAbs for feline infectious peritonitis
por: Doki, Tomoyoshi, et al.
Publicado: (2013)

Crystal structure analysis of anti-V2 mAb 2158 suggests a conformational epitope involving an N-linked glycan
por: Spurrier, B, et al.
Publicado: (2012)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dlthc589londvl68grjaqiu071